I am a senior principal scientist in health economics and outcomes research at the Global MSD team. I lead the development of global and country-specific pharmacoeconomic models to support HTA submissions and product launches for multiple oncology indications across the world. My main interest is in the implementation of cost-effectiveness models that meet HTA requirements.

After graduating in Economics (Univ. of La Laguna, Spain) and Health Economics (University of York, UK), I worked in the public health sector (Canaries Health Service, Spain), academia (Centre for Reviews and Dissemination, University of York; London School of Hygiene and Tropical Medicine, London) and consultancy (York Health Economics Consortium, i3Innovus and Amaris) before joining MSD in 2014. I became part of the Global MSD team in 2017.